Montelukast Sodium Intermediates Market 2025: Growth Trends, Innovations & Industry Forecast | Manus Aktteva Biopharma, Ortin Laboratories, PGShah & Co

LOS ANGELES, United States: QY Research has recently published a research report titled, "Montelukast Sodium Intermediates - Market Insights, Industry Share, Sales Projections, and Demand Outlook 2024-2030" assessing various factors impacting its trajectory. The global Montelukast Sodium Intermediates market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Montelukast Sodium Intermediates market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Montelukast Sodium Intermediates market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Montelukast Sodium Intermediates market. We have also focused on SWOT, PESTLE, and Porter's Five Forces analyses of the global Montelukast Sodium Intermediates market.

The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/chemical-material-montelukast-sodium-intermediates-market-insights-industry-share-sales-projections-and-demand-outlook-2024-2030

The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global Montelukast Sodium Intermediates market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the Montelukast Sodium Intermediates business.

Competitive Analysis

Leading players of the global Montelukast Sodium Intermediates market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Montelukast Sodium Intermediates market. Furthermore, the report offers two separate market forecasts - one for the production side and another for the consumption side of the global Montelukast Sodium Intermediates market. It also provides useful recommendations for new as well as established players of the global Montelukast Sodium Intermediates market.

Details of Montelukast Sodium Intermediates Market Segmentation: -

Key Players Mentioned in the Global Montelukast Sodium Intermediates Market Research Report:

Manus Aktteva Biopharma
Ortin Laboratories
PGShah & Co
VIVAN Life Sciences
Arch Pharmalabs
Actis Generics
Morepen Laboratories
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Medopharm
Nenter & Co., Inc
Ruiweier Biotechnology
Arromax Pharmatech
Alpha Pharmaceutical
Kangfeidi Chemical
Anqing Rock Pharmaceutical
BioChem Partner
Dongyue Pharma
WeiShi Reagent

Segment by Type

Aromatic Amines
Ethers
Esters
Others

Segment by Application

Pharmaceuticals
Scientific Research
Others

The segmental analysis section of the report includes a thorough research study on key type and application segments of the global Montelukast Sodium Intermediates market. All of the segments considered for the study are analyzed in quite some detail on the basis of market share, growth rate, recent developments, technology, and other critical factors. The segmental analysis provided in the report will help players to identify high-growth segments of the global Montelukast Sodium Intermediates market and clearly understand their growth journey.

Regional segmentation is an essential part of the Montelukast Sodium Intermediates research report. It analyzes the various regions that the market is segmented on the basis of and evaluates the various influencers. Changing political scenarios, impact of national budgets, governing polices, and importance given to global policies by certain regions and countries has also been discussed in this part of the Montelukast Sodium Intermediates research report.

Report Objectives

(1) Analyzing the size of the global Montelukast Sodium Intermediates market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Montelukast Sodium Intermediates market

(3) Exploring key dynamics of the global Montelukast Sodium Intermediates market

(4) Highlighting important trends of the global Montelukast Sodium Intermediates market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Montelukast Sodium Intermediates market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Montelukast Sodium Intermediates market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Market Forecasting

For long-term market forecasting, our researchers used technological market models, whereas econometric models were used for short-term market forecasting. These models are basically based on an amalgamation of studies related to business principles, economic outlook, regulatory frameworks, and technology landscape. We used a bottom-up approach for market estimation to ensure minimum errors. Use of a bottom-up approach is also critical for providing a deep understanding of the concerned industry.

We considered the following parameters for market forecasting. The market impact of these parameters was quantified and assigned weights to with the help of weighted average analysis.

(A) Current capacity and expected capacity additions up to 2031

(B) Expected developments and regulatory scenarios

(C) Supply versus price trends and raw material scenarios

(D) Current and expected impact of market drivers and restraints

Unlock Exclusive Market Insights - Customize Your Research Report Now! https://www.qyresearch.in/report-details/8037526/Montelukast-Sodium-Intermediates---Market-Insights

Table of Contents

1 Market Overview
1.1 Montelukast Sodium Intermediates Product Introduction
1.2 Global Montelukast Sodium Intermediates Market Size Forecast
1.2.1 Global Montelukast Sodium Intermediates Sales Value (2020-2031)
1.2.2 Global Montelukast Sodium Intermediates Sales Volume (2020-2031)
1.2.3 Global Montelukast Sodium Intermediates Sales Price (2020-2031)
1.3 Montelukast Sodium Intermediates Market Trends & Drivers
1.3.1 Montelukast Sodium Intermediates Industry Trends
1.3.2 Montelukast Sodium Intermediates Market Drivers & Opportunity
1.3.3 Montelukast Sodium Intermediates Market Challenges
1.3.4 Montelukast Sodium Intermediates Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global Montelukast Sodium Intermediates Players Revenue Ranking (2024)
2.2 Global Montelukast Sodium Intermediates Revenue by Company (2020-2025)
2.3 Global Montelukast Sodium Intermediates Players Sales Volume Ranking (2024)
2.4 Global Montelukast Sodium Intermediates Sales Volume by Company Players (2020-2025)
2.5 Global Montelukast Sodium Intermediates Average Price by Company (2020-2025)
2.6 Key Manufacturers Montelukast Sodium Intermediates Manufacturing Base and Headquarters
2.7 Key Manufacturers Montelukast Sodium Intermediates Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Montelukast Sodium Intermediates
2.9 Montelukast Sodium Intermediates Market Competitive Analysis
2.9.1 Montelukast Sodium Intermediates Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Montelukast Sodium Intermediates Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Sodium Intermediates as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Aromatic Amines
3.1.2 Ethers
3.1.3 Esters
3.1.4 Others
3.2 Global Montelukast Sodium Intermediates Sales Value by Type
3.2.1 Global Montelukast Sodium Intermediates Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Montelukast Sodium Intermediates Sales Value, by Type (2020-2031)
3.2.3 Global Montelukast Sodium Intermediates Sales Value, by Type (%) (2020-2031)
3.3 Global Montelukast Sodium Intermediates Sales Volume by Type
3.3.1 Global Montelukast Sodium Intermediates Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Montelukast Sodium Intermediates Sales Volume, by Type (2020-2031)
3.3.3 Global Montelukast Sodium Intermediates Sales Volume, by Type (%) (2020-2031)
3.4 Global Montelukast Sodium Intermediates Average Price by Type (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Montelukast Sodium Intermediates Sales Value by Application
4.2.1 Global Montelukast Sodium Intermediates Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Montelukast Sodium Intermediates Sales Value, by Application (2020-2031)
4.2.3 Global Montelukast Sodium Intermediates Sales Value, by Application (%) (2020-2031)
4.3 Global Montelukast Sodium Intermediates Sales Volume by Application
4.3.1 Global Montelukast Sodium Intermediates Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Montelukast Sodium Intermediates Sales Volume, by Application (2020-2031)
4.3.3 Global Montelukast Sodium Intermediates Sales Volume, by Application (%) (2020-2031)
4.4 Global Montelukast Sodium Intermediates Average Price by Application (2020-2031)

5 Segmentation by Region
5.1 Global Montelukast Sodium Intermediates Sales Value by Region
5.1.1 Global Montelukast Sodium Intermediates Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Montelukast Sodium Intermediates Sales Value by Region (2020-2025)
5.1.3 Global Montelukast Sodium Intermediates Sales Value by Region (2026-2031)
5.1.4 Global Montelukast Sodium Intermediates Sales Value by Region (%), (2020-2031)
5.2 Global Montelukast Sodium Intermediates Sales Volume by Region
5.2.1 Global Montelukast Sodium Intermediates Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Montelukast Sodium Intermediates Sales Volume by Region (2020-2025)
5.2.3 Global Montelukast Sodium Intermediates Sales Volume by Region (2026-2031)
5.2.4 Global Montelukast Sodium Intermediates Sales Volume by Region (%), (2020-2031)
5.3 Global Montelukast Sodium Intermediates Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Montelukast Sodium Intermediates Sales Value, 2020-2031
5.4.2 North America Montelukast Sodium Intermediates Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Montelukast Sodium Intermediates Sales Value, 2020-2031
5.5.2 Europe Montelukast Sodium Intermediates Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Montelukast Sodium Intermediates Sales Value, 2020-2031
5.6.2 Asia Pacific Montelukast Sodium Intermediates Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Montelukast Sodium Intermediates Sales Value, 2020-2031
5.7.2 South America Montelukast Sodium Intermediates Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Montelukast Sodium Intermediates Sales Value, 2020-2031
5.8.2 Middle East & Africa Montelukast Sodium Intermediates Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Montelukast Sodium Intermediates Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Montelukast Sodium Intermediates Sales Value and Sales Volume
6.2.1 Key Countries/Regions Montelukast Sodium Intermediates Sales Value, 2020-2031
6.2.2 Key Countries/Regions Montelukast Sodium Intermediates Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Montelukast Sodium Intermediates Sales Value, 2020-2031
6.3.2 United States Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Montelukast Sodium Intermediates Sales Value, 2020-2031
6.4.2 Europe Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Montelukast Sodium Intermediates Sales Value, 2020-2031
6.5.2 China Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.5.3 China Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Montelukast Sodium Intermediates Sales Value, 2020-2031
6.6.2 Japan Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Montelukast Sodium Intermediates Sales Value, 2020-2031
6.7.2 South Korea Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Montelukast Sodium Intermediates Sales Value, 2020-2031
6.8.2 Southeast Asia Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Montelukast Sodium Intermediates Sales Value, 2020-2031
6.9.2 India Montelukast Sodium Intermediates Sales Value by Type (%), 2024 VS 2031
6.9.3 India Montelukast Sodium Intermediates Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 Manus Aktteva Biopharma
7.1.1 Manus Aktteva Biopharma Company Information
7.1.2 Manus Aktteva Biopharma Introduction and Business Overview
7.1.3 Manus Aktteva Biopharma Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Manus Aktteva Biopharma Montelukast Sodium Intermediates Product Offerings
7.1.5 Manus Aktteva Biopharma Recent Development
7.2 Ortin Laboratories
7.2.1 Ortin Laboratories Company Information
7.2.2 Ortin Laboratories Introduction and Business Overview
7.2.3 Ortin Laboratories Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Ortin Laboratories Montelukast Sodium Intermediates Product Offerings
7.2.5 Ortin Laboratories Recent Development
7.3 PGShah & Co
7.3.1 PGShah & Co Company Information
7.3.2 PGShah & Co Introduction and Business Overview
7.3.3 PGShah & Co Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 PGShah & Co Montelukast Sodium Intermediates Product Offerings
7.3.5 PGShah & Co Recent Development
7.4 VIVAN Life Sciences
7.4.1 VIVAN Life Sciences Company Information
7.4.2 VIVAN Life Sciences Introduction and Business Overview
7.4.3 VIVAN Life Sciences Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 VIVAN Life Sciences Montelukast Sodium Intermediates Product Offerings
7.4.5 VIVAN Life Sciences Recent Development
7.5 Arch Pharmalabs
7.5.1 Arch Pharmalabs Company Information
7.5.2 Arch Pharmalabs Introduction and Business Overview
7.5.3 Arch Pharmalabs Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Arch Pharmalabs Montelukast Sodium Intermediates Product Offerings
7.5.5 Arch Pharmalabs Recent Development
7.6 Actis Generics
7.6.1 Actis Generics Company Information
7.6.2 Actis Generics Introduction and Business Overview
7.6.3 Actis Generics Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Actis Generics Montelukast Sodium Intermediates Product Offerings
7.6.5 Actis Generics Recent Development
7.7 Morepen Laboratories
7.7.1 Morepen Laboratories Company Information
7.7.2 Morepen Laboratories Introduction and Business Overview
7.7.3 Morepen Laboratories Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Morepen Laboratories Montelukast Sodium Intermediates Product Offerings
7.7.5 Morepen Laboratories Recent Development
7.8 TAPI
7.8.1 TAPI Company Information
7.8.2 TAPI Introduction and Business Overview
7.8.3 TAPI Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 TAPI Montelukast Sodium Intermediates Product Offerings
7.8.5 TAPI Recent Development
7.9 MSN Laboratories
7.9.1 MSN Laboratories Company Information
7.9.2 MSN Laboratories Introduction and Business Overview
7.9.3 MSN Laboratories Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 MSN Laboratories Montelukast Sodium Intermediates Product Offerings
7.9.5 MSN Laboratories Recent Development
7.10 Ultratech India
7.10.1 Ultratech India Company Information
7.10.2 Ultratech India Introduction and Business Overview
7.10.3 Ultratech India Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Ultratech India Montelukast Sodium Intermediates Product Offerings
7.10.5 Ultratech India Recent Development
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Company Information
7.11.2 Aurobindo Pharma Introduction and Business Overview
7.11.3 Aurobindo Pharma Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Aurobindo Pharma Montelukast Sodium Intermediates Product Offerings
7.11.5 Aurobindo Pharma Recent Development
7.12 Medopharm
7.12.1 Medopharm Company Information
7.12.2 Medopharm Introduction and Business Overview
7.12.3 Medopharm Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Medopharm Montelukast Sodium Intermediates Product Offerings
7.12.5 Medopharm Recent Development
7.13 Nenter & Co., Inc
7.13.1 Nenter & Co., Inc Company Information
7.13.2 Nenter & Co., Inc Introduction and Business Overview
7.13.3 Nenter & Co., Inc Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Nenter & Co., Inc Montelukast Sodium Intermediates Product Offerings
7.13.5 Nenter & Co., Inc Recent Development
7.14 Ruiweier Biotechnology
7.14.1 Ruiweier Biotechnology Company Information
7.14.2 Ruiweier Biotechnology Introduction and Business Overview
7.14.3 Ruiweier Biotechnology Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Ruiweier Biotechnology Montelukast Sodium Intermediates Product Offerings
7.14.5 Ruiweier Biotechnology Recent Development
7.15 Arromax Pharmatech
7.15.1 Arromax Pharmatech Company Information
7.15.2 Arromax Pharmatech Introduction and Business Overview
7.15.3 Arromax Pharmatech Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Arromax Pharmatech Montelukast Sodium Intermediates Product Offerings
7.15.5 Arromax Pharmatech Recent Development
7.16 Alpha Pharmaceutical
7.16.1 Alpha Pharmaceutical Company Information
7.16.2 Alpha Pharmaceutical Introduction and Business Overview
7.16.3 Alpha Pharmaceutical Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Alpha Pharmaceutical Montelukast Sodium Intermediates Product Offerings
7.16.5 Alpha Pharmaceutical Recent Development
7.17 Kangfeidi Chemical
7.17.1 Kangfeidi Chemical Company Information
7.17.2 Kangfeidi Chemical Introduction and Business Overview
7.17.3 Kangfeidi Chemical Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Kangfeidi Chemical Montelukast Sodium Intermediates Product Offerings
7.17.5 Kangfeidi Chemical Recent Development
7.18 Anqing Rock Pharmaceutical
7.18.1 Anqing Rock Pharmaceutical Company Information
7.18.2 Anqing Rock Pharmaceutical Introduction and Business Overview
7.18.3 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Product Offerings
7.18.5 Anqing Rock Pharmaceutical Recent Development
7.19 BioChem Partner
7.19.1 BioChem Partner Company Information
7.19.2 BioChem Partner Introduction and Business Overview
7.19.3 BioChem Partner Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 BioChem Partner Montelukast Sodium Intermediates Product Offerings
7.19.5 BioChem Partner Recent Development
7.20 Dongyue Pharma
7.20.1 Dongyue Pharma Company Information
7.20.2 Dongyue Pharma Introduction and Business Overview
7.20.3 Dongyue Pharma Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Dongyue Pharma Montelukast Sodium Intermediates Product Offerings
7.20.5 Dongyue Pharma Recent Development
7.21 WeiShi Reagent
7.21.1 WeiShi Reagent Company Information
7.21.2 WeiShi Reagent Introduction and Business Overview
7.21.3 WeiShi Reagent Montelukast Sodium Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 WeiShi Reagent Montelukast Sodium Intermediates Product Offerings
7.21.5 WeiShi Reagent Recent Development

8 Industry Chain Analysis
8.1 Montelukast Sodium Intermediates Industrial Chain
8.2 Montelukast Sodium Intermediates Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Montelukast Sodium Intermediates Sales Model
8.5.2 Sales Channel
8.5.3 Montelukast Sodium Intermediates Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.com
Tel: +91-8669986909
Email- ankit@qyresearch.com

This release was published on openPR.